Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UTHR |
---|---|---|
09:32 ET | 3247 | 312.65 |
09:36 ET | 587 | 312.675 |
09:38 ET | 630 | 312.79 |
09:39 ET | 300 | 311.7487 |
09:41 ET | 100 | 312.03 |
09:43 ET | 800 | 312.5 |
09:45 ET | 100 | 312.82 |
09:48 ET | 400 | 313 |
09:54 ET | 1284 | 312.355 |
09:57 ET | 503 | 312.535 |
09:59 ET | 100 | 312.16 |
10:01 ET | 500 | 311.69 |
10:08 ET | 600 | 311.71 |
10:10 ET | 917 | 311.915 |
10:12 ET | 200 | 311.61 |
10:15 ET | 302 | 311.83 |
10:17 ET | 1150 | 312.42 |
10:19 ET | 100 | 313 |
10:21 ET | 100 | 313.035 |
10:24 ET | 262 | 313.36 |
10:26 ET | 561 | 313.66 |
10:28 ET | 400 | 313.675 |
10:30 ET | 348 | 313.42 |
10:32 ET | 100 | 313.59 |
10:33 ET | 413 | 313.61 |
10:35 ET | 515 | 313.78 |
10:37 ET | 500 | 313.33 |
10:42 ET | 300 | 313.13 |
10:44 ET | 200 | 313.29 |
10:48 ET | 200 | 313.03 |
10:55 ET | 400 | 311.99 |
10:57 ET | 1100 | 312.21 |
11:00 ET | 500 | 311.87 |
11:02 ET | 200 | 311.87 |
11:04 ET | 600 | 312.42 |
11:09 ET | 100 | 313.16 |
11:11 ET | 800 | 313.355 |
11:18 ET | 700 | 313.44 |
11:20 ET | 1000 | 313.62 |
11:27 ET | 300 | 313.625 |
11:29 ET | 200 | 313.705 |
11:31 ET | 796 | 313.71 |
11:33 ET | 1507 | 313.845 |
11:36 ET | 101 | 313.6736 |
11:40 ET | 200 | 313.81 |
11:44 ET | 711 | 313.82 |
11:45 ET | 400 | 314.12 |
11:49 ET | 100 | 314.08 |
11:51 ET | 350 | 314.03 |
11:54 ET | 873 | 313.985 |
11:58 ET | 237 | 313.84 |
12:03 ET | 136 | 312.83 |
12:07 ET | 900 | 313.265 |
12:09 ET | 100 | 313.305 |
12:12 ET | 100 | 313.03 |
12:14 ET | 400 | 313.01 |
12:20 ET | 200 | 313.055 |
12:25 ET | 100 | 312.96 |
12:27 ET | 510 | 312.9 |
12:32 ET | 100 | 312.79 |
12:36 ET | 200 | 313.07 |
12:38 ET | 1254 | 313.1 |
12:39 ET | 950 | 313.07 |
12:48 ET | 300 | 313.06 |
12:56 ET | 100 | 313.14 |
01:06 ET | 200 | 313.17 |
01:08 ET | 198 | 313.17 |
01:10 ET | 400 | 313.35 |
01:12 ET | 2337 | 313.15 |
01:14 ET | 205 | 312.39 |
01:15 ET | 100 | 312.12 |
01:17 ET | 100 | 312.55 |
01:19 ET | 363 | 312.458 |
01:21 ET | 200 | 312.395 |
01:24 ET | 200 | 312.302 |
01:30 ET | 400 | 311.99 |
01:35 ET | 700 | 312.14 |
01:37 ET | 600 | 312.67 |
01:39 ET | 400 | 312.6 |
01:42 ET | 200 | 312.44 |
01:44 ET | 100 | 312.68 |
01:46 ET | 100 | 312.83 |
01:48 ET | 200 | 312.575 |
01:50 ET | 102 | 312.71 |
01:51 ET | 100 | 312.83 |
01:53 ET | 435 | 312.55 |
01:57 ET | 904 | 312.83 |
02:02 ET | 420 | 312.66 |
02:04 ET | 100 | 312.765 |
02:06 ET | 117 | 312.6392 |
02:09 ET | 313 | 312.55 |
02:13 ET | 500 | 312.465 |
02:15 ET | 100 | 312.33 |
02:20 ET | 700 | 312.69 |
02:22 ET | 199 | 312.96 |
02:26 ET | 300 | 313.02 |
02:27 ET | 100 | 313.08 |
02:31 ET | 100 | 313.15 |
02:33 ET | 100 | 313.1 |
02:38 ET | 233 | 313.14 |
02:40 ET | 516 | 312.93 |
02:42 ET | 100 | 312.965 |
02:45 ET | 119 | 312.79 |
02:47 ET | 200 | 312.98 |
02:49 ET | 732 | 312.91 |
02:54 ET | 510 | 313.0381 |
02:58 ET | 616 | 313.22 |
03:00 ET | 102 | 313.17 |
03:02 ET | 200 | 313.17 |
03:05 ET | 100 | 313.38 |
03:07 ET | 2756 | 312.89 |
03:09 ET | 400 | 313.285 |
03:14 ET | 2560 | 313.0085 |
03:18 ET | 100 | 313.34 |
03:20 ET | 100 | 313.73 |
03:21 ET | 325 | 313.8 |
03:23 ET | 200 | 313.745 |
03:27 ET | 1053 | 313.585 |
03:30 ET | 100 | 313.42 |
03:32 ET | 678 | 313.11 |
03:34 ET | 100 | 313.055 |
03:36 ET | 200 | 312.97 |
03:38 ET | 503 | 313.18 |
03:39 ET | 300 | 313.37 |
03:41 ET | 846 | 313.915 |
03:43 ET | 1100 | 313.85 |
03:45 ET | 400 | 314 |
03:48 ET | 1642 | 313.79 |
03:52 ET | 2516 | 313.65 |
03:54 ET | 640 | 314.12 |
03:56 ET | 1869 | 314.84 |
03:57 ET | 3332 | 314.45 |
03:59 ET | 111640 | 314.56 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
United Therapeutics Corp | 14.0B | 14.9x | +8.22% |
Biomarin Pharmaceutical Inc | 15.5B | 76.1x | --- |
Beigene Ltd | 16.2B | -19.4x | --- |
Neurocrine Biosciences Inc | 14.0B | 38.2x | +62.04% |
Medpace Holdings Inc | 12.5B | 41.0x | +35.10% |
Exact Sciences Corp | 8.2B | -33.6x | --- |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.0B |
---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.55 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 14.9x |
Price/Sales (TTM) | 5.6 |
Price/Cash Flow (TTM) | 12.6x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.